Cultured AFB Antitubercular DST Levofloxacin Test
Comprehensive Tuberculosis Drug Sensitivity Testing
The Cultured AFB Antitubercular DST Levofloxacin Test represents a critical advancement in tuberculosis management, specifically designed to evaluate the effectiveness of levofloxacin against Mycobacterium tuberculosis strains. This sophisticated diagnostic tool plays an essential role in combating drug-resistant tuberculosis, which has become an increasingly significant global health concern.
What This Test Measures and Detects
This specialized test precisely measures the sensitivity of cultured Mycobacterium tuberculosis bacteria to levofloxacin, a fluoroquinolone antibiotic commonly used as a second-line treatment for tuberculosis. The test determines:
- Minimum inhibitory concentration (MIC) of levofloxacin against TB bacteria
- Presence of genetic mutations associated with levofloxacin resistance
- Effectiveness of levofloxacin as part of multi-drug TB regimens
- Potential for cross-resistance with other fluoroquinolone medications
Who Should Consider This Test
This test is particularly important for individuals experiencing:
- Persistent cough lasting more than three weeks despite initial TB treatment
- Unexplained weight loss and night sweats continuing after starting therapy
- Previous treatment failure for tuberculosis
- Known exposure to drug-resistant TB strains
- Immunocompromised conditions requiring precise TB medication selection
- Healthcare workers with potential TB exposure
- Patients from regions with high rates of drug-resistant tuberculosis
Key Benefits of Levofloxacin Sensitivity Testing
Undergoing this specialized testing provides numerous advantages:
- Personalized Treatment Planning: Enables healthcare providers to design customized TB treatment regimens based on specific bacterial sensitivity profiles
- Prevention of Treatment Failure: Identifies resistance early to avoid ineffective therapy and disease progression
- Reduced Side Effects: Helps eliminate unnecessary medications that may cause adverse reactions
- Cost-Effective Care: Prevents spending on medications that won’t work for your specific TB strain
- Public Health Protection: Contributes to controlling the spread of drug-resistant tuberculosis in communities
Understanding Your Test Results
Your test results will provide clear guidance on levofloxacin effectiveness:
- Sensitive Result: Indicates levofloxacin is likely to be effective against your TB strain, making it a viable treatment option
- Resistant Result: Shows that levofloxacin will not be effective, requiring alternative second-line medications
- Intermediate Sensitivity: Suggests levofloxacin may work at higher doses or in combination with other drugs
Your physician will interpret these results in the context of your overall health status and develop a comprehensive treatment plan accordingly.
Test Pricing Information
| Test Name | Discount Price | Regular Price |
|---|---|---|
| Cultured AFB Antitubercular DST Levofloxacin Test | $84 USD | $92 USD |
Convenient Testing Locations Across the USA
We maintain comprehensive testing facilities throughout major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, and San Jose. Our state-of-the-art laboratories ensure consistent, reliable results regardless of your location.
Take Control of Your Tuberculosis Treatment Today
Don’t leave your TB treatment to chance. The Cultured AFB Antitubercular DST Levofloxacin Test provides the critical information needed to ensure your treatment is effective and tailored to your specific bacterial strain. With results available in 21 days and samples accepted daily until 3:30 PM, getting the answers you need has never been more convenient.
Ready to get started? Book your test now or call our dedicated healthcare team at +1(267) 388-9828 to schedule your appointment. Take the first step toward effective tuberculosis management today.
